cell therapy
Cell therapy partnership aims to bring liver disease treatment closer to US patients
September 1, 2026Resolution Therapeutics, US, cell therapy, liver disease
Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery of its experimental cell therapy …
Major breakthrough in T-cell receptor therapy manufacturing
November 27, 2025Manufacturing and Production Terumo BCT, cell therapy
For the first time, researchers at the University of Chicago in the US have successfully completed all three critical steps …
Eyestem secures $10m to advance cell therapy for advanced eye disease
August 13, 2025Medical Communications, Research and Development Eyestem, Opthalmology, cell therapy, dry age-related macular degeneration, geographic atrophy
Indian cell therapy company, Eyestem Research, has raised $10m in a funding round to support development of its investigational retinal …
Sartorius Stedim Biotech partners with Nanotein Technologies to develop cell therapy manufacturing
August 12, 2025Mergers and Acquisitions Corporate, Nanotein Technologies, Sartorius Stedim Biotech, cell therapy, gene therapy
Sartorius Stedim Biotech has partnered with Nanotein Technologies to expand access to immune cell activation reagents for cell therapy manufacturing. …
Terumo BCT showcases new CAR-T workflow enabling faster cell expansion
June 20, 2025Manufacturing and Production CAR-T cell manufacturing, Devices, EULV, Eureka Biotechnology, Terumo Blood and Cell Technologies, cell therapy, eureka, gene therapy
Terumo Blood and Cell Technologies (Terumo BCT) has unveiled a new automated workflow that consolidates three critical CAR-T manufacturing steps …
First UK patient treated with CSL Behring’s gene therapy for Haemophilia B
June 20, 2025Research and Development CSL Behring, Haematology, NHS England, cell therapy, gene therapy, haemophilia B, prophylactic infusions
CSL Behring has announced that the first patient in the UK has received HEMGENIX (etranacogene dezaparvovec) through the NHS, marking …
Eyestem completes phase 1 trial of retinal cell therapy with promising vision gains
June 20, 2025Research and Development Eyestem Research, Opthalmology, cell therapy, clinical trial, dry age-related macular degeneration, geographic atrophy
Eyestem Research has announced the successful completion of its phase 1 trial evaluating Eyecyte-RPE, an investigational cell therapy for geographic …
ViroCell and UCL launch trial to treat childhood leukaemia relapse
April 24, 2025Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia
ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …
Galapagos announces leadership changes amid planned company split
April 22, 2025Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy
Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …
Successful trial results announced for potential rare eye disease treatment
April 14, 2025Research and Development Eyestem, Opthalmology, age-related macular degeneration (AMD), biotech, cell therapy, eye disease
Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for …
Bit.bio announces cell therapy pipeline
November 8, 2023Medical Communications Hepatology, bit.bio, cell therapy, liver failure
Bit.bio has announced its cell therapy pipeline as well as having shared its lead cell therapy candidate, preparing to enter …
AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development
November 1, 2023Research and Development AstraZeneca, CGT, Pharmacy, cell therapy, cellectis, genomic medicine
AstraZeneca has announced a collaboration and investment agreement with Cellectis for the development of next generation cell and gene therapeutics …
Japanese researchers to trial stem cell therapy in four patients with serious spinal injuries
February 19, 2019Manufacturing and Production Japan, Keio University, Parkinson's, cell therapy, iPS
The Japanese health ministry has approved a study testing the use of induced pluripotent stem (iPS) cells to treat four …
Celgene signs deals with two Massachusetts-based biotechs
January 21, 2019Sales and Marketing Celgene, Kyn, Obsidian, cell therapy, immuno oncology, immuno-oncology
New Jersey-based biotechnology firm Celgene has signed deals with two Massachusetts-based biotechs: immuno-oncology specialist Kyn therapeutics and cell therapy firm …
US regulator to recruit 50 new gene and cell therapy clinical reviewers
January 16, 2019Research and Development FDA, cell therapy, gene therapy, regulation
FDA Commissioner Scott Gottlieb has said that the agency hopes to recruit 50 additional clinical reviewers for the group that …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
